Seeking Alpha

Alnylam Pharma (ALNY +3.2%) gets a positive opinion for Orphan Drug Designation from European...

Alnylam Pharma (ALNY +3.2%) gets a positive opinion for Orphan Drug Designation from European Medicines Agency for its ALN-TTR01, an RNAi therapeutic. (PR)
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs